Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2161 AL 2175

Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson's disease subtype

Mamais A, Wallings R, Rocha EM.

Handb Clin Neurol. 2023;193:33-51. doi: 10.1016/B978-0-323-85555-6.00009-6.

Noninvasive Neuromodulation in Parkinson's Disease: Insights from Animal Models

Muksuris K, Scarisbrick DM, Mahoney JJ 3rd, Cherkasova MV.

J Clin Med. 2023 Aug 22;12(17):5448. doi: 10.3390/jcm12175448.

Optimization of inpatient medication administration among persons with Parkinson's disease: recommendations on pharmacy technology and workflow

Yu JRT, Sokola BS, Walter BL.

Front Pharmacol. 2023 Nov 14;14:1254757. doi: 10.3389/fphar.2023.1254757. eCollection 2023.

Molecular Imaging of Parkinson’s Disease

Shogbesan G, Schroeder HW III, Newallo D, Hall LT.

In: Hall LT, editor. Molecular Imaging and Therapy [Internet]. Brisbane (AU): Exon Publications; 2023 Nov 8. Chapter 1.

A Paradigm Shift in the Management of Patients with Parkinson's Disease

Tsamis KI, Odin P, Antonini A, Reichmann H, Konitsiotis S.

Neurodegener Dis. 2023;23(1-2):13-19. doi: 10.1159/000533798. Epub 2023 Nov 1.

Concomitant protein pathogenesis in Parkinson's disease and perspective mechanisms

Han Y, He Z.

Front Aging Neurosci. 2023 Apr 27;15:1189809. doi: 10.3389/fnagi.2023.1189809. eCollection 2023.

Differentiated Embryo-Chondrocyte Expressed Gene1 and Parkinson's Disease: New Insights and Therapeutic Perspectives

Wang CY, Qiu ZJ, Zhang P, Tang XQ.

Curr Neuropharmacol. 2023;21(11):2251-2265. doi: 10.2174/1570159X21666230502123729.

Tools and criteria to select patients with advanced Parkinson's disease for device-aided therapies: a narrative review

Moes HR, Henriksen T, Sławek J, Phokaewvarangkul O, Buskens E, van Laar T.

J Neural Transm (Vienna). 2023 Nov;130(11):1359-1377. doi: 10.1007/s00702-023-02656-z. Epub 2023 Jul 27.

Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential

Henrich MT, Oertel WH, Surmeier DJ, Geibl FF.

Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7.

An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease

Komori T, Kuwahara T.

Biomolecules. 2023 Nov 13;13(11):1645. doi: 10.3390/biom13111645.

Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease

Chu C, Yu L, Li Y, Guo H, Zhai Q, Chen W, Tian F.

Food Funct. 2023 Apr 24;14(8):3406-3422. doi: 10.1039/d2fo03825k.

A case of early-onset Parkinson's disease in a patient with KBG syndrome

Magistrelli L, Contaldi E, Caushi F, Spano A, Cantello R, D'Alfonso S, Corrado L.

Neurol Sci. 2023 Dec;44(12):4537-4539. doi: 10.1007/s10072-023-06988-2. Epub 2023 Aug 4.

Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson's Disease

Peña-Díaz S, García-Pardo J, Ventura S.

Pharmaceutics. 2023 Mar 3;15(3):839. doi: 10.3390/pharmaceutics15030839.

Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research

Khan MA, Haider N, Singh T, Bandopadhyay R, Ghoneim MM, Alshehri S, Taha M, Ahmad J, Mishra A.

Metab Brain Dis. 2023 Mar;38(3):873-919. doi: 10.1007/s11011-023-01180-z. Epub 2023 Feb 20.

Risk of impulse control disorders in patients with Cushing's disease: do not blame cabergoline but do not give up caution

Sulu C, Gul N, Tanrikulu S, Ciftci S, Yener Ozturk F, Sarac B, Ersungur EB, Tanriover E, Sahin S, Ozkaya HM, Poyraz BC, Kadioglu P.

Pituitary. 2023 Aug;26(4):495-509. doi: 10.1007/s11102-023-01342-3. Epub 2023 Jul 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias